Search – Page 56 – Indianapolis Business Journal

Home » Search

Articles

IU School of Medicine wins $12.3M grant to study opioid withdrawal treatment

September 18, 2020 | John Russell

The medical school said it is testing the use of tezampanel, an experimental drug for migraines developed by Indianapolis-based drugmaker Eli Lilly and Co., to treat opioid withdrawal syndrome and other addictions and mental illnesses.

Study hints Lilly antibody drug might cut COVID-19 hospitalizations

September 16, 2020 | Associated Press

Wednesday’s results come from 450 people in a mid-stage study testing an antibody jointly developed by Lilly and the Canadian company AbCellera in people with COVID-19 symptoms not severe enough to warrant hospitalization.

Lilly anti-inflammatory drug might shorten COVID-19 recovery time

September 14, 2020 | Associated Press

Eli Lilly announced the results Monday from a 1,000-person study sponsored by the U.S. National Institute of Allergy and Infectious Diseases.

Lilly’s Jardiance pill could get boost to blockbuster status with latest findings

August 31, 2020 | John Russell

Lilly and partner Boehringer Ingelheim published results from a trial showing the drug cut the risk of cardiovascular hospitalizations or death by 25%, compared to placebo in heart failure patients.

Editorial: Lilly spinoff wasting no time in quest for global growth

August 28, 2020

So far, Elanco has been a textbook case for the benefits of spinoffs—for both the parent company divesting the business and the division gaining its independence.

Pharmacists allowed to give childhood vaccinations under new directive

August 20, 2020 | Associated Press

In 2018, only about 7% of childhood flu shots were administered at pharmacies, according to CDC data. And it’s even rarer for other childhood shots to be given at drug stores.

2020 CTO of the Year: Jared Adams

August 19, 2020 | Tom Harton

Adams, the senior vice president of product engineering at Jobvite, has led the company’s recent advancements on the artificial intelligence front with machine learning and sentiment analysis, as well as analytics.

EVA DANIELS: Barriers, stigma still hold back people with disabilities

August 14, 2020 | Eva Daniels

People with disabilities are unemployed and underemployed to a greater extent than their able-bodied peers and face lower wages, misunderstanding and limitations on their earning capacity if they must rely on essential things such as attendant care.

Companies test antibody drugs to treat, prevent COVID-19

August 12, 2020 | Associated Press

With a coronavirus vaccine still months off, companies—including Indianapolis-based Eli Lilly and Co.—are rushing to test what might be the next best thing: drugs that deliver antibodies to fight the virus.

Elanco’s big job: Making the Bayer deal work

August 7, 2020 | John Russell

Now that the company has closed its $6.9 billion acquisition of the German conglomerate’s animal-health division, it must now swiftly and carefully integrate the two sprawling companies in the midst of a pandemic.

Independent music venues face closures without help

August 7, 2020 | Mickey Shuey

About 60 entertainment stages, bars and studios across Indiana have joined forces in a new association to fight for government assistance they say is needed to survive.

Lilly Endowment awards $100M for initiative focusing on Indy’s Black community

August 5, 2020 | IBJ Staff

The newly formed Indianapolis African American Quality of Life Renewal Initiative will seek to encourage collaboration and resource sharing between public, private and civic institutions.

Lilly to start testing experimental treatment for COVID-19 in nursing homes

August 3, 2020 | John Russell

The Indianapolis-based drugmaker said it will enroll about 2,400 residents and staff of nursing homes to test an antibody it is developing with a Canadian biotech. Nursing homes account for about 40% of U.S. deaths from COVID-19.

IU researcher’s latest biotech startup raises $34.6M

July 27, 2020 | John Russell

Carmel-based MBX Biosciences Inc., co-founded by serial entrepreneur Richard DiMarchi, aims to develop therapeutics to treat rare endocrine disorders.

Lilly, IU School of Medicine team up on $5M immunology research pact

July 22, 2020 | IBJ Staff

Under the agreement, researchers will study patients who used Lilly autoimmune therapies that are under consideration for the treatment of other autoimmune diseases, including inflammatory bowel disease and psoriasis.

Lilly seeking $23.8M tax break to expand diabetes research, production

July 21, 2020 | John Russell

In the past seven years, the drugmaker has received tax breaks worth nearly $40 million in exchange for investing more than $500 million at its Indianapolis properties.

Lumina Foundation to devote $15M to dismantling systemic racism

July 20, 2020 | Mason King

The Indianapolis-based grant maker intends about 25% of the money to help organizations and initiatives in Indiana over three years. Half a million dollars already has been committed to the Central Indiana Racial Equity Fund.

Elanco gets U.S. regulatory approval for $7.6B Bayer acquisition

July 15, 2020 | IBJ Staff

Shares in Elanco rose 2.8% Wednesday morning after the approval was announced, to $24.13 each.

Downtown firms in no rush to get workers back to office

July 10, 2020 | Samm Quinn and Anthony Schoettle

It could be months, or longer, before downtown bustles again with the office workers who help restaurants and other retailers thrive. And the wait might be a death knell for some of those retailers.

« Previous 1 … 54 55 56 57 58 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'